1. Home
  2. TRDA vs CVLG Comparison

TRDA vs CVLG Comparison

Compare TRDA & CVLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • CVLG
  • Stock Information
  • Founded
  • TRDA 2016
  • CVLG 1986
  • Country
  • TRDA United States
  • CVLG United States
  • Employees
  • TRDA N/A
  • CVLG N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • CVLG Trucking Freight/Courier Services
  • Sector
  • TRDA Health Care
  • CVLG Industrials
  • Exchange
  • TRDA Nasdaq
  • CVLG Nasdaq
  • Market Cap
  • TRDA 609.7M
  • CVLG 689.1M
  • IPO Year
  • TRDA 2021
  • CVLG 1994
  • Fundamental
  • Price
  • TRDA $17.63
  • CVLG $54.02
  • Analyst Decision
  • TRDA Strong Buy
  • CVLG Strong Buy
  • Analyst Count
  • TRDA 3
  • CVLG 2
  • Target Price
  • TRDA $21.67
  • CVLG $70.00
  • AVG Volume (30 Days)
  • TRDA 166.9K
  • CVLG 51.9K
  • Earning Date
  • TRDA 11-05-2024
  • CVLG 10-23-2024
  • Dividend Yield
  • TRDA N/A
  • CVLG 0.82%
  • EPS Growth
  • TRDA N/A
  • CVLG N/A
  • EPS
  • TRDA 3.04
  • CVLG 3.07
  • Revenue
  • TRDA $239,397,000.00
  • CVLG $1,128,966,000.00
  • Revenue This Year
  • TRDA $39.06
  • CVLG $7.83
  • Revenue Next Year
  • TRDA N/A
  • CVLG $7.73
  • P/E Ratio
  • TRDA $5.76
  • CVLG $17.55
  • Revenue Growth
  • TRDA 451.22
  • CVLG N/A
  • 52 Week Low
  • TRDA $10.75
  • CVLG $38.25
  • 52 Week High
  • TRDA $18.17
  • CVLG $56.96
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 61.79
  • CVLG 58.83
  • Support Level
  • TRDA $15.65
  • CVLG $50.59
  • Resistance Level
  • TRDA $18.01
  • CVLG $54.52
  • Average True Range (ATR)
  • TRDA 0.75
  • CVLG 1.37
  • MACD
  • TRDA 0.17
  • CVLG 0.27
  • Stochastic Oscillator
  • TRDA 86.52
  • CVLG 89.45

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

About CVLG Covenant Logistics Group Inc.

Covenant Logistics Group Inc together with its wholly-owned subsidiaries offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight and Warehousing. Expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. Managed Freight segment includes brokerage services and TMS. Warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function. Majority of revenue is generated from expedited segment.

Share on Social Networks: